vs
Grove Collaborative Holdings, Inc.（GROV）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Grove Collaborative Holdings, Inc.的1.6倍（$69.8M vs $42.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -3.7%，领先387.8%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -14.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -11.0%）
Grove Collaborative控股公司是一家公益企业，总部位于美国旧金山，在缅因州波特兰设有额外办事处。该企业以自有品牌Grove Co.推出并销售自有环保家居及个人护理产品，同时也代理销售其他品牌的相关产品，主打绿色可持续的日用消费品类目。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
GROV vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.6倍
$42.4M
营收增速更快
RIGL
高出35.5%
-14.3%
净利率更高
RIGL
高出387.8%
-3.7%
两年增速更快
RIGL
近两年复合增速
-11.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $42.4M | $69.8M |
| 净利润 | $-1.6M | $268.1M |
| 毛利率 | 53.0% | 91.5% |
| 营业利润率 | -3.7% | 33.2% |
| 净利率 | -3.7% | 384.0% |
| 营收同比 | -14.3% | 21.2% |
| 净利润同比 | 87.5% | 1769.2% |
| 每股收益（稀释后） | $-0.06 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GROVRIGL
| Q4 25 | $42.4M | $69.8M | ||
| Q3 25 | $43.7M | $69.5M | ||
| Q2 25 | $44.0M | $101.7M | ||
| Q1 25 | $43.5M | $53.3M | ||
| Q4 24 | $49.5M | $57.6M | ||
| Q3 24 | $48.3M | $55.3M | ||
| Q2 24 | $52.1M | $36.8M | ||
| Q1 24 | $53.5M | $29.5M |
净利润GROVRIGL
| Q4 25 | $-1.6M | $268.1M | ||
| Q3 25 | $-3.0M | $27.9M | ||
| Q2 25 | $-3.6M | $59.6M | ||
| Q1 25 | $-3.5M | $11.4M | ||
| Q4 24 | $-12.6M | $14.3M | ||
| Q3 24 | $-1.3M | $12.4M | ||
| Q2 24 | $-10.1M | $-1.0M | ||
| Q1 24 | $-3.4M | $-8.2M |
毛利率GROVRIGL
| Q4 25 | 53.0% | 91.5% | ||
| Q3 25 | 53.3% | 93.2% | ||
| Q2 25 | 55.4% | 95.6% | ||
| Q1 25 | 53.0% | 91.7% | ||
| Q4 24 | 52.4% | 89.9% | ||
| Q3 24 | 53.0% | 85.5% | ||
| Q2 24 | 53.9% | 92.4% | ||
| Q1 24 | 55.5% | 93.1% |
营业利润率GROVRIGL
| Q4 25 | -3.7% | 33.2% | ||
| Q3 25 | -6.2% | 40.9% | ||
| Q2 25 | -7.9% | 60.1% | ||
| Q1 25 | -8.1% | 23.9% | ||
| Q4 24 | -16.8% | 28.9% | ||
| Q3 24 | -14.0% | 25.4% | ||
| Q2 24 | -13.3% | 1.2% | ||
| Q1 24 | -1.0% | -23.6% |
净利率GROVRIGL
| Q4 25 | -3.7% | 384.0% | ||
| Q3 25 | -6.8% | 40.2% | ||
| Q2 25 | -8.2% | 58.6% | ||
| Q1 25 | -8.1% | 21.5% | ||
| Q4 24 | -25.5% | 24.9% | ||
| Q3 24 | -2.8% | 22.5% | ||
| Q2 24 | -19.3% | -2.8% | ||
| Q1 24 | -6.3% | -27.9% |
每股收益（稀释后）GROVRIGL
| Q4 25 | $-0.06 | $14.11 | ||
| Q3 25 | $-0.08 | $1.46 | ||
| Q2 25 | $-0.10 | $3.28 | ||
| Q1 25 | $-0.10 | $0.63 | ||
| Q4 24 | $-0.34 | $0.82 | ||
| Q3 24 | $-0.04 | $0.70 | ||
| Q2 24 | $-0.28 | $-0.06 | ||
| Q1 24 | $-0.10 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.5M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $-17.0M | $391.5M |
| 总资产 | $53.1M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资GROVRIGL
| Q4 25 | $8.5M | $155.0M | ||
| Q3 25 | $8.9M | $137.1M | ||
| Q2 25 | $10.0M | $108.4M | ||
| Q1 25 | $9.6M | $77.1M | ||
| Q4 24 | $19.6M | $77.3M | ||
| Q3 24 | $50.8M | $61.1M | ||
| Q2 24 | $78.8M | $49.1M | ||
| Q1 24 | $77.8M | $49.5M |
总债务GROVRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | $32.2M | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益GROVRIGL
| Q4 25 | $-17.0M | $391.5M | ||
| Q3 25 | $-16.1M | $117.6M | ||
| Q2 25 | $-14.0M | $81.9M | ||
| Q1 25 | $-11.6M | $18.6M | ||
| Q4 24 | $-8.5M | $3.3M | ||
| Q3 24 | $1.5M | $-14.6M | ||
| Q2 24 | $686.0K | $-29.9M | ||
| Q1 24 | $7.5M | $-31.7M |
总资产GROVRIGL
| Q4 25 | $53.1M | $513.6M | ||
| Q3 25 | $54.6M | $242.5M | ||
| Q2 25 | $57.8M | $206.7M | ||
| Q1 25 | $59.8M | $176.0M | ||
| Q4 24 | $65.0M | $164.0M | ||
| Q3 24 | $105.2M | $139.4M | ||
| Q2 24 | $131.8M | $128.4M | ||
| Q1 24 | $137.9M | $126.5M |
负债/权益比GROVRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | 21.16× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.0K | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-62.0K | — |
| 自由现金流率自由现金流/营收 | -0.1% | — |
| 资本支出强度资本支出/营收 | 0.1% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-8.1M | — |
8季度趋势，按日历期对齐
经营现金流GROVRIGL
| Q4 25 | $-29.0K | $22.0M | ||
| Q3 25 | $-1.0M | $24.0M | ||
| Q2 25 | $987.0K | $30.5M | ||
| Q1 25 | $-6.9M | $-893.0K | ||
| Q4 24 | $270.0K | $14.5M | ||
| Q3 24 | $750.0K | $21.7M | ||
| Q2 24 | $1.6M | $302.0K | ||
| Q1 24 | $-12.4M | $-5.0M |
自由现金流GROVRIGL
| Q4 25 | $-62.0K | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | $556.0K | — | ||
| Q1 25 | $-7.4M | — | ||
| Q4 24 | $-95.0K | — | ||
| Q3 24 | $264.0K | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $-12.9M | — |
自由现金流率GROVRIGL
| Q4 25 | -0.1% | — | ||
| Q3 25 | -2.7% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | -17.0% | — | ||
| Q4 24 | -0.2% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 2.3% | — | ||
| Q1 24 | -24.1% | — |
资本支出强度GROVRIGL
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.0% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 0.7% | — | ||
| Q1 24 | 1.0% | — |
现金转化率GROVRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GROV
| Third Party Products | $23.4M | 55% |
| Grove Brands | $19.0M | 45% |
RIGL
暂无分部数据
